liu.seSearch for publications in DiVA
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Nerve growth factor in serum of children with systemic lupus erythematosus is correlated with disease activity
Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.
Department of Neuroscience, Neurobiology, Uppsala University, Box 587, S-75123, Uppsala, Sweden.
Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.
Hospital for Children and Adolescents, University of Helsinki, Helsinki, Finland.
Show others and affiliations
2002 (English)In: Cytokine, ISSN 1043-4666, E-ISSN 1096-0023, Vol. 20, no 3, p. 136-139Article in journal (Refereed) Published
Abstract [en]

Nerve growth factor (NGF) is a neurotrophic factor, which is expressed both in the nervous system and in peripheral organs. NGF is also present in mast cells, and in B- and T-lymphocytes, and may play a role in the immune cell development and differentiation. Various cytokines have been shown to affect NGF expression, and NGF is elevated in inflammation and in some autoimmune diseases. Here we have studied NGF concentrations in serum of pediatric patients with systemic lupus erythematosus (SLE) using a two-site enzyme-linked immunosorbent assay (ELISA). We have further correlated the levels of NGF to the inflammatory state of the disease. The mean value of serum NGF in SLE patients was significantly increased compared with controls (3346 vs 627 pg/ml). There was a correlation between the activity of SLE and the levels of NGF. The results show that NGF is elevated in childhood SLE and that the levels are correlated with disease activity. The present results suggest that NGF may play a role in the pathogenesis of SLE and may have a prognostic value in evaluating the course of the disease and in outlining the medication. (C) 2002 Elsevier Science Ltd. All rights reserved.

Place, publisher, year, edition, pages
ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD , 2002. Vol. 20, no 3, p. 136-139
Keywords [en]
SLE, nerve growth factor, enzyme-linked immunosorbent, assay, serum, inflammation
National Category
Neurosciences
Identifiers
URN: urn:nbn:se:liu:diva-167998DOI: 10.1006/cyto.2002.1991ISI: 000179674800006PubMedID: 12453472OAI: oai:DiVA.org:liu-167998DiVA, id: diva2:1457452
Available from: 2020-08-11 Created: 2020-08-11 Last updated: 2021-06-11Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed
In the same journal
Cytokine
Neurosciences

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 467 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • oxford
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf